Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Endo Plans to Open New Manufacturing Facility in India
Endo, Inc announces its plans to open a new aseptic manufacturing facility in Indore, India This cuttingedge 20,000squarefoot facility is specifically designed for the aseptic manufacturing of sterile injectable products
Macsen Labs Group Plans for the Construction of New Manufacturing Facility in India
Macsen Labs Group has announced the commencement of construction of a new Active Pharmaceutical Ingredient API manufacturing facility in India
Novo Nordisk Invests US$1.18 billion (DKK 8.5 billion) for New Production Facility in Denmark
Novo Nordisk plans to invest US$118 billion DKK 85 billion in opening a cuttingedge production facility in Odense, Denmark
BioCentriq Invests US$12 million to Expand Cell Therapy Manufacturing Facility in USA
BioCentriq palns to invest a stateoftheart cell therapy manufacturing facility in New Jersey, USA
Indiana University Invests US$138 million for State-of-the-Art Bioscience Facility in USA
Indiana University palns to invest US$138 million to open a new stateoftheart facility in USA
Afton Scientific Invests US$200 million to Expand Biopharmaceutical Manufacturing Facility in USA
Afton Scientific plans to invest US$200 million to expand its biopharmaceutical manufacturing facility in Albemarle County, USA
FUJIFILM Diosynth Biotechnologies Unveils Global CDMO Ecosystem Expansion in Denmark
FUJIFILM Diosynth Biotechnologies is planning the first phase of its expansion at the Hillerd facility in Denmark
Orano Moed Invests US$262.7 million (€250 mn) for New Production Facility in USA
Orano Moed is set to invest US$2627 million 250 million in a new Advanced Thorium Extraction Facility ATEF in the USA
GSK Invests US$800 million to Open New State-of-the-art Drug Manufacturing Facility in USA
GSK plans to invests US$800 million to open new stateoftheart facilities for the production of medicines and vaccinesin USA
Eli Lilly Invests US$3 billion to Expand Manufacturing Facility in Wisconsin, USA
Eli Lilly plans to invest US$3 billion for the expansion of its manufacturing facility in Wisconsin, USA
